13 results
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
drugs. In February 2023, CMS published its report which described three potential models focusing on affordability, accessibility and feasibility … networks, or financial arrangements. In addition, in the last few years, several states have formed prescription drug affordability boards (“PDABs
S-1/A
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
in additional reductions in Medicare and other healthcare funding, which may materially negatively affect customer demand and affordability for our drug
S-1
IXHL
Incannex Healthcare Limited
3 Jul 24
IPO registration
6:29am
and affordability for our drug candidates and, accordingly, the results of our financial operations. Also, there has been heightened governmental
20-F
2022 FY
IXHL
Incannex Healthcare Limited
28 Oct 22
Annual report (foreign)
6:31am
funding, which may materially negatively affect customer demand and affordability for our drug candidates and, accordingly, the results of our financial
20FR12B/A
hhbyb9mk ptpa4l
24 Feb 22
Initial registration of securities (foreign private issuers) (amended)
3:42pm
20FR12B/A
4nrua
22 Feb 22
Initial registration of securities (foreign private issuers) (amended)
6:10am
20FR12B
we8luyssvdu4hdrh1fr5
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
F-1/A
eon8fz 6qk1iy7hk08q
7 Dec 21
Registration statement (foreign) (amended)
5:21pm
F-1/A
54630n019wjfypo9
23 Nov 21
Registration statement (foreign) (amended)
3:28pm
F-1/A
pwsjcqpruy o75
3 Nov 21
Registration statement (foreign) (amended)
6:06am
F-1/A
iv8nwnfjd1 ka7yhotx
28 Sep 21
Registration statement (foreign) (amended)
6:06am
F-1
r9d utkpea
17 Aug 21
Registration statement (foreign)
4:39pm
- Prev
- 1
- Next